during the at any time-evolving environment of diabetic issues and pounds management investigation, Tirzepatide stands out as a groundbreaking Resolution. With its dual motion on GLP-1 and GIP receptors, this peptide has shown promising results in regulating blood sugar and advertising and marketing weightloss. Researchers and Health care suppliers